HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â04¿ù19ÀÏfri
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-04-19 17:18:24
´º½ºÈ¨ > Àλç
2021³â04¿ù01ÀÏ 10½Ã26ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
Çѱ¹¾Öºêºñ, ±èµ¿¿í¡¤ÃÖ¿ÁÈñ ÀÌ»ç »ó¹«·Î ½ÂÁø ¹ß·É

[º¸°ÇŸÀÓÁî] Çѱ¹¾Öºêºñ(ÁÖ)(´ëÇ¥ÀÌ»ç °­¼Ò¿µ)´Â 4¿ù 1ÀÏ Á¤±â Àλ翡¼­ Ä¿½ºÅÍ¸Ó ¿¢¼³·±½º¸¦ ÃÑ°ýÇÏ°í ÀÖ´Â ±èµ¿¿í(ÑÑÔÔéô. ¸¸ 47¼¼/»çÁø ñ§) ÀÌ»ç¿Í ÀÓ»ó½ÃÇèºÎ¼­¸¦ ÃÑ°ýÇÏ´Â ÃÖ¿ÁÈñ(õËè¬ýï ¸¸ 45¼¼/éÓ) À̻縦 °¢°¢ »ó¹«·Î ÀÓ¸í ¹ßÇ¥Çß´Ù.

±èµ¿¿í »ó¹«´Â Çѱ¹¿À°¡³íÀÇ ¸¶ÄÉÆà ºÎ¼­¿Í 2008³â Çѱ¹¾Öº¸Æ® ÇÁ¶óÀ̸Ӹ®ÄÉ¾î »ç¾÷ºÎ¿¡¼­ ¸¶ÄÉÆðú ¿µ¾÷ ¸Å´ÏÀú·Î ±Ù¹«Çß´Ù. Çѱ¹¾Öºêºñ ½ºÆä¼ÈƼÄÉ¾î »ç¾÷ºÎ ¸Å´ÏÀú¸¦ °ÅÃÄ ¸¶ÄÉÆà ÃÑ°ýÀ» ¿ªÀÓÇÑ ÈÄ, 2020³âºÎÅÍ Ä¿½ºÅÍ¸Ó ¿¢¼³·±½º(Customer Excellence) ºÎ¼­¸¦ ¸Ã°í ÀÖ´Ù.

±è »ó¹«´Â °í·Á´ëÇб³ ³ó»ý¹°Çаú¸¦ Á¹¾÷Çß°í, µ¿ ´ëÇÐÀÇ °æ¿µ´ëÇпø¿¡¼­ °æ¿µÇÐ ¼®»ç ÇÐÀ§¸¦ ÃëµæÇß´Ù.

ÃÖ¿ÁÈñ »ó¹«´Â Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓÀÇ ¾Æ½Ã¾Æ Áö¿ª ÇÁ·ÎÁ§Æ® ¸Å´ÏÀú, Çѱ¹¿ÀÃ÷Ä« ÀÓ»ó½ÃÇèÆÀÀåÀ» ¿ªÀÓÇß´Ù. 2011ºÎÅÍ Çѱ¹¾Öº¸Æ®¿Í Çѱ¹¾ÖºêºñÀÇ ÀÓ»ó½ÃÇèºÎ¼­(Clinical Site Management)¸¦ ÃÑ°ýÇØ ¿Ô´Ù.

ÃÖ »ó¹«´Â ¼­¿ï´ëÇб³ ¾àÇдëÇÐ Á¦¾àÇаú¸¦ Á¹¾÷Çß°í, µ¿ ´ëÇÐÀÇ ¾à¹°µ¿ÅÂÇÐ ¼®»ç ÇÐÀ§¸¦ ÃëµæÇß´Ù.

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
Á¶ÇöÁø (bktimes@naver. com) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
Àλ缽¼Ç ¸ñ·ÏÀ¸·Î
Çϳª·Î ÀÇ·áÀç´Ü–¼Ò...
µ¿Åº½ÃƼº´¿ø, °üÀý¼¾ÅÍ Àü...
±¹¸³¾Ï¼¾ÅÍ ´ë¿ÜÇù·Â½ÇÀå¿¡...
°è¸í´ë µ¿»êº´¿øÀå¿¡ 'Á¶Ä¡...
³ëµ¿¿µ ¾Ïº´¿øÀå À¯¹æ°Ç°­...
´ÙÀ½±â»ç : Àϵ¿Á¦¾à±×·ì Á¤±â ÀÎ»ç ¹ß·É (2021-04-01 11:13:46)
ÀÌÀü±â»ç : Çѱ¹¿¤·¯°£-¾Öºêºñ ÄÄÆÛ´Ï, 'ÀüÇöÁ¤ ÀÌ»ç' ¹ß·É (2021-04-01 10:14:39)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Overcoming BRAF and CDK4/6 inhibitor ...  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶